Neurophysiological Examination in Patients With Brain Death
Neurophysiological Study in Patients With Brain Death: A Single Center Prospective Study
1 other identifier
observational
10
1 country
1
Brief Summary
This study examines muscle movements of elecromyography in adults with brain death. Half of the participants will have brain death, the other half will be healthy volunteers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2017
CompletedFirst Submitted
Initial submission to the registry
August 19, 2017
CompletedFirst Posted
Study publicly available on registry
August 25, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2019
CompletedOctober 10, 2019
October 1, 2019
1 year
August 19, 2017
October 8, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Axonal response
Measure of axonal response by electromyography
Within 72 hours from brain death diagnosis
Study Arms (1)
Patients with brain death
Ten patients with definite etiology, who were diagnosed with brain death because of Apnea test positive and / or cranial reflexes were not available and were male and female patients aged 18-72 years
Eligibility Criteria
Patients in the adult intensive care unit
You may qualify if:
- Adult patients with definite diagnosis of brain death,
- Patients with permission from their parents,
- Patients without trauma of medullaspinalis and peripheral nerve injuries,
- Patients without previously known muscle disease (Myasthenia gravis, myopathy, etc.),
- Patients with previously unknown neurological disease (Amyotrophic Lateral Sclerosis, Multiple sclerosis, Guillain Barre syndrome, Poliomyelitis, etc.),
- Patients who have not previous systemic diseases (Connective Tissue Disease, Diabetes mellitus, Chronic renal failure, etc.).
You may not qualify if:
- Uncertain brain death,
- Patients without permission of family members,
- Younger than 18 years old and older than 72 years,
- Patients with medulla spinalis and peripheral nerve injuries,
- Patients with known muscle disease (Myasthenia gravis, myopathy, etc.),
- Patients with neurological disease (Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Guillain Barre Syndrome, Poliomyelitis, etc.),
- Patients with previous systemic diseases (Connective Tissue Disease, Diabetes, Chronic Kidney Failure, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yuzuncu Yil University, School of Medicine
Van, Tusba / Zeve Kampus, 65080, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Hilmi Demirkiran, MD
Department of Anethesiology and Reanimation
- PRINCIPAL INVESTIGATOR
Aydin Cagac, MD
Department of Neurology
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 19, 2017
First Posted
August 25, 2017
Study Start
May 15, 2017
Primary Completion
May 15, 2018
Study Completion
September 15, 2019
Last Updated
October 10, 2019
Record last verified: 2019-10